BMC Cancer 2008, 8:36 http://www.biomedcentral.com/1471-2407/8/36 Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998, 16:441-452. 62. Collins LC, Rubin MA, Schnitt SJ: Are tissue microarrays useful for the study of pre-invasive breast lesions? Breast Cancer Res Treat 2004, 88:S191. 63. Yang XR, Charette LA, Garcia-Closas M, Lissowska J, Paal E, Sidawy M, Hewitt SM, Rimm DL, Sherman ME: Construction and valida- tion of tissue microarrays of ductal carcinoma in situ and ter- minal duct lobular units associated with invasive breast carcinoma. Diagn Mol Pathol 2006, 15:157-161. 64. Jirstrom K, Ringberg A, Ferno M, Anagnostaki L, Landberg G: Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence. Br J Cancer 2003, 89:1920-1926. 65. Barnes NL, Khavari S, Boland GP, Cramer A, Knox WF, Bundred NJ: Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast. Clin Cancer Res 2005, 11:2163-2168. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/8/36/prepub Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 11 of 11 (page number not for citation purposes)